Ivonescimab is a next-generation bispecific antibody that simultaneously targets programmed cell death protein 1 (PD-1) and vascular endothelial growth factor (VEGF), two key molecules in the tumour ...
Download this handbook to learn more about the capabilities of mass photometry for evaluating antibody aggregation and ...
Mass photometry is an analytical technique used to investigate biomolecules at the single-particle level. It is able to analyze these particles in their native state and without the need for labels.
Mass photometry is a fast and powerful tool for adeno-associated virus analytics with single-particle resolution.
Automated mass photometry combines the unparalleled simplicity and sensitivity of Refeyn’s molecular mass measurement technology with the efficiency and ease of automation. This approach offers ...
In this GEN webinar Ray Zhang, PhD, associate director, QC-Analytics at Franklin Biolabs will introduce the principles of mass photometry and highlight where it adds value across the analytical ...
Mass photometry is a novel bioanalytical technology that provides insights into the mass distribution of biomolecules in their native state within minutes, without the need for labeling, surface ...
Serotonin is often referred to as the "happiness molecule." It plays a critical role in affecting mood levels and is also a neurotransmitter that sends signals within the brain and the body.
Refeyn has announced that mass photometry has been recognized by the US Pharmacopeia (USP) – and referenced in the new draft USP general chapter <1067> – as a key orthogonal method for characterizing ...
MOST methods of heterochromatic photometry currently employed are based on dual optical systems, consisting of two beams of light which pass through appropriate filters and fall on two photo-cells. We ...
ABSTRACT I present a new analysis of CCD‐based BVRI broadband photometry for the globular cluster NGC 2419, based on 340 CCD images either donated by colleagues or retrieved from public archives. The ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results